News - Cardio-vascular, Servier, Research

Filter

XOMA's perindopril and amlodipine FDC meets primary endpoint in Ph III blood pressure trial

23-11-2012

California, USA-based XOMA Corp (Nasdaq: XOMA) says the 837-patient Phase III PATH trial (Perindopril…

Amlodipine BesylateCardio-vascularLicensingNorth AmericaperindoprilPharmaceuticalResearchServierXOMA Corp

Back to top